Private company

Affimed N.V.

Last updated Oct 16, 2026.

Overview

8.3MRevenue, fiscal 20232
-105.9MNet income, fiscal 20232
  • IndustryPharmaceutical Preparations
  • Headquarters2M
  • Incorporated inGermany3
  • Business addressGottlieb-Daimler-Strasse 2, Mannheim, 2M 681653
  • Filer categoryAccelerated filer3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in EUR, the currency the company reports in.

Key numbers, fiscal 2023

-1289.0%Operating margin2
-1280.2%Net margin2
-80.0%Revenue growth, 20232
-183.3%Return on equity2
-114.0M EURFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Other costs100¢8.3M EUR

Out of 8.3M EUR in revenue.2 The company lost money this year.

Financial statements

Revenue4567828.3M EUR in 2023+31% since 2016
020.0M EUR40.0M EUR60.0M EUR2016: 6.3M EUR6.3M EUR20162017: 2.0M EUR2.0M EUR2017−68%2018: 23.7M EUR23.7M EUR2018+1081%2019: 21.4M EUR21.4M EUR2019−10%2020: 28.4M EUR28.4M EUR2020+33%2021: 40.4M EUR40.4M EUR2021+42%2022: 41.4M EUR41.4M EUR2022+2%2023: 8.3M EUR8.3M EUR2023−80%
Operating income456782-106.7M EUR in 2023+233% since 2016
-150.0M EUR-100.0M EUR-50.0M EUR02016: -32.0M EUR-32.0M EUR20162017: -27.3M EUR-27.3M EUR2017−15%2018: -19.5M EUR-19.5M EUR2018−28%2019: -32.4M EUR-32.4M EUR2019+66%2020: -34.7M EUR-34.7M EUR2020+7%2021: -64.0M EUR-64.0M EUR2021+84%2022: -88.1M EUR-88.1M EUR2022+38%2023: -106.7M EUR-106.7M EUR2023+21%
Net income456782-105.9M EUR in 2023+229% since 2016
-150.0M EUR-100.0M EUR-50.0M EUR02016: -32.2M EUR-32.2M EUR20162017: -30.2M EUR-30.2M EUR2017−6%2018: -19.5M EUR-19.5M EUR2018−36%2019: -32.4M EUR-32.4M EUR2019+66%2020: -41.4M EUR-41.4M EUR2020+28%2021: -57.5M EUR-57.5M EUR2021+39%2022: -86.0M EUR-86.0M EUR2022+50%2023: -105.9M EUR-105.9M EUR2023+23%
Fiscal year20162017201820192020202120222023
Revenue6.3M EUR42.0M EUR523.7M EUR621.4M EUR728.4M EUR840.4M EUR241.4M EUR28.3M EUR2
Operating income-32.0M EUR4-27.3M EUR5-19.5M EUR6-32.4M EUR7-34.7M EUR8-64.0M EUR2-88.1M EUR2-106.7M EUR2
Net income-32.2M EUR4-30.2M EUR5-19.5M EUR6-32.4M EUR7-41.4M EUR8-57.5M EUR2-86.0M EUR2-105.9M EUR2
Earnings per share-0 EUR/shares8-5 EUR/shares2-6 EUR/shares2-7 EUR/shares2
Earnings per share (diluted)-0 EUR/shares8-5 EUR/shares2-6 EUR/shares2-7 EUR/shares2

Compare Affimed N.V. with another company

Former names

  • Affimed Therapeutics B.V.May 23, 2014 to Sep 16, 20143

Recent filings

  1. May 14, 20256-K
  2. May 13, 20256-K
  3. Apr 21, 20256-K
  4. Dec 17, 20246-K
  5. Nov 14, 20246-K
  6. Oct 15, 20246-K
  7. Sep 11, 20246-K
  8. Sep 5, 20246-K
  9. Sep 3, 20246-K
  10. Jun 26, 20246-K
  11. Jun 12, 20246-K
  12. Jun 3, 20246-K
  13. May 28, 20246-K
  14. May 23, 20246-K
  15. Mar 28, 202420-F

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9